×

Barings Serves as Joint Lead Arranger in Ridgemont Equity Partners’ Acquisition of HemaSource

CHARLOTTE, N.C., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Barings, a leading global financial services firm with over $288 billion in assets under management, announced today that it served as a Joint Lead Arranger in a senior credit facility supporting Ridgemont Equity Partners’ acquisition of HemaSource. The deal closed on July 19, 2017 and NXT Capital served as Administrative Agent on the senior credit facility.

HemaSource, headquartered in West Jordan, Utah, is the leading technology-enabled distributor of consumable medical products to plasma collection centers. The company utilizes a proprietary cloud-based inventory management and business intelligence software solution to help its customers gain supply chain efficiencies and decrease plasma collection costs.

“Barings’ institutional knowledge of lending in both the healthcare and value-added distribution industries, as well as their ability to move quickly on a tight timeline, were critical factors in selecting them as a Joint Lead Arranger,” said Scott Poole, Partner at Ridgemont Equity Partners. “As we look to continue HemaSource’s strong track record of organic growth, as well as supplement that with selective acquisitions, we are glad to have the support of Barings and our other financing partners.”

“We are excited to have the opportunity to partner with Ridgemont on its investment in HemaSource, representing our third deal with the firm and second this year,” stated Justin Lay, Managing Director for Barings. “HemaSource holds strong market share in an industry with tremendous momentum, and we are looking forward to supporting its continued growth.”

With over 650 investment professionals, including more than 70 dedicated solely to private finance, Barings leverages its global presence and local expertise to source private credit investments in developed markets worldwide. This global sourcing network, coupled with a diverse portfolio of platform companies, provides Barings with ongoing opportunities to finance middle market transactions including new platform investments, add-on acquisitions and recapitalizations across the U.S., Europe and Asia.

About HemaSource

HemaSource Intermediate Holdings, LLC, is the leading technology-enabled distributor of medical products to the plasma collection industry. The company is headquartered in West Jordan, Utah, and distributes consumable products across 1,300 SKUs from two strategically located distribution centers. HemaSource utilizes a proprietary cloud-based inventory management and business intelligence software solution to help its customers gain supply chain efficiencies and decrease their plasma collection costs. Plasma-derived therapeutics like IVIG, Albumin and Factor VIII treat immunodeficiency diseases, neurological disorders and hematology conditions. www.hemasource.com

About Ridgemont Equity Partners

Ridgemont Equity Partners is a Charlotte-based middle market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $3.5 billion in 139 companies. The firm focuses on investments of $25 million to $100 million in industries in which it has deep expertise, including basic industries and services, energy, healthcare, and telecommunications/media/technology.
www.ridgemontep.com

About Barings LLC

Barings is a $288+ billion* global financial services firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 650 investment professionals and offices in 16 countries. Learn more at www.barings.com.

*As of June 30, 2017

17/565

Contact: Brian Whelan, Barings, (980) 417-7700, brian.whelan@barings.com

Source: Barings